BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Human chorionic gonadotropin
,
Doxorubicin
,
rs2476601
,
CYP51
,
Inflammatory disorder
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
atypical carcinoid tumour
Summary
General Info
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
Transcript Profiling of Cancer Cell Line Panel
Explore Curated Studies Results
Literature
Most Relevant Literature
Subcutaneous metastasis from an atypical pulmonary carcinoid tumor.
A National Study of Surgically Managed Atypical Pulmonary Carcinoid Tumors.
Next generation sequencing can be helpful in histologic diagnosis: A case report of metastatic breas…
Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypic…
Role of orthopedia homebox protein in subclassification of pulmonary carcinoid tumors: Retrospective…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Axitinib in Advanced Carcinoid Tumors
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ